Drug Trial Radar · NCT06143956
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Last checked: Nov 19, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,481
Planned (sponsor's estimate)
Start
Nov 17, 2023
Primary completion
Sep 2027
Study completion Feb 2028
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Nov 22, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Screening
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight management with intervention-specific appendices (ISAs). The CWMM establishes entry criteria for newly enrolled participants across the master and the ISAs. The ISAs may start independently of other ISAs as interventions become available for clinical testing. The results for the CWMM screening record will be reported when all the ISA's complete.
Conditions
- Obesity
- Overweight
Interventions
LY3305677Drug
Administered SC. ISA specific interventions will be listed in the ISA.
LY3841136Drug
Administered SC. ISA specific interventions will be listed in the ISA.
TirzepatideDrug
Administered SC. ISA specific interventions will be listed in the ISA.
LY3549492Drug
Administered orally. ISA specific interventions will be listed in the ISA.
LY3532226Drug
Administered SC. ISA specific interventions will be listed in the ISA.
PlaceboDrug
Administered SC. ISA specific interventions will be listed in the ISA.
PlaceboDrug
Administered orally. ISA specific interventions will be listed in the ISA.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Allocated to Each ISATime frame: Baseline to Week 6
Locations
57 sites in 2 countries. Site status is shown where the registry gives one.
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa
Chandler, Arizona · Recruiting
HOPE Research Institute
Phoenix, Arizona · Completed
Headlands Research - Scottsdale
Scottsdale, Arizona · Recruiting
The Institute for Liver Health II dba Arizona Liver Health-Tucson
Tucson, Arizona · Recruiting
NorCal Medical Research, Inc
Greenbrae, California · Recruiting
Velocity Clinical Research, Huntington Park
Huntington Park, California · Recruiting
Peninsula Research Associates
Rolling Hills Estates, California · Recruiting
Diablo Clinical Research, Inc.
Walnut Creek, California · Recruiting
Stamford Therapeutics Consortium
Stamford, Connecticut · Recruiting
Northeast Research Institute (NERI)
Fleming Island, Florida · Completed
New Horizon Research Center
Miami, Florida · Recruiting
Indago Research & Health Center, Inc
Miami Lakes, Florida · Recruiting
Suncoast Clinical Research, Inc.
New Port Richey, Florida · Recruiting
Charter Research - Winter Park
Orlando, Florida · Recruiting
Charter Research - Lady Lake
The Villages, Florida · Recruiting
Pacific Diabetes & Endocrine Center
Honolulu, Hawaii · Completed
Medical Research Partners
Ammon, Idaho · Recruiting
Great Lakes Clinical Trials - Ravenswood
Chicago, Illinois · Active not recruiting
Great Lakes Clinical Trials - Ravenswood
Chicago, Illinois · Recruiting
NorthShore University Health System
Skokie, Illinois · Completed
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa · Recruiting
Cotton O'Neil Diabetes & Endocrinology
Topeka, Kansas · Recruiting
Monroe Biomedical Research - Louisville
Louisville, Kentucky · Recruiting
Knownwell
Needham, Massachusetts · Recruiting
Lucida Clinical Trials
New Bedford, Massachusetts · Recruiting
Headlands Research - Detroit
Southfield, Michigan · Recruiting
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division
Troy, Michigan · Recruiting
StudyMetrix Research
City of Saint Peters, Missouri · Recruiting
Clinvest Headlands Llc
Springfield, Missouri · Recruiting
Las Vegas Medical Research
Las Vegas, Nevada · Recruiting
Dent Neurologic Institute
Amherst, New York · Recruiting
Velocity Clinical Research, Syracuse
East Syracuse, New York · Recruiting
North Suffolk Neurology
Port Jefferson Station, New York · Completed
Rochester Clinical Research, LLC
Rochester, New York · Recruiting
Medication Management
Greensboro, North Carolina · Recruiting
Monroe Biomedical Research
Monroe, North Carolina · Recruiting
Lucas Research, Inc
Morehead City, North Carolina · Recruiting
Lucas Research, Inc.
New Bern, North Carolina · Recruiting
CTI Clinical Research Center
Cincinnati, Ohio · Recruiting
Tribe Clinical Research, LLC
Greenville, South Carolina · Recruiting
Showing 40 of 57 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.